Compare TKNO & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TKNO | ALTI |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | 490 |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.1M | 492.8M |
| IPO Year | 2021 | 2021 |
| Metric | TKNO | ALTI |
|---|---|---|
| Price | $7.24 | $4.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 167.5K | ★ 198.3K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.86 | 41.11 |
| EPS | ★ N/A | N/A |
| Revenue | $40,520,000.00 | ★ $254,956,000.00 |
| Revenue This Year | $8.27 | $18.06 |
| Revenue Next Year | $13.13 | $10.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.35 | ★ 23.21 |
| 52 Week Low | $1.91 | $2.75 |
| 52 Week High | $7.84 | $5.45 |
| Indicator | TKNO | ALTI |
|---|---|---|
| Relative Strength Index (RSI) | 74.88 | 54.43 |
| Support Level | $3.79 | $3.86 |
| Resistance Level | N/A | $4.38 |
| Average True Range (ATR) | 0.55 | 0.30 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 80.06 | 42.80 |
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.